GLP-1 Agonists Discovery

Nick explains the short half-life of human-derived GLP-1 and its metabolism rate. Neil clarifies the concept of half-life using physics. The discovery of GLP-1 agonists from lizard venom by John in the 1990s is discussed, highlighting the fascinating origin of these treatments.